Topcon Europe Medical to distribute LensAR product line in Europe

Topcon Europe Medical BV (Rotterdam, Netherlands) and LensAR Inc (Orlando, Florida) announce their intent to enter into a long term strategic cooperation. Topcon Europe Medical BV will be responsible for the distribution and marketing the LensAR product line in Europe. Both companies expect to start commercial sales in Europe in the first quarter of 2012. The LensAR™ Laser System will be demonstrated in the Topcon booth at the upcoming ESCRS meeting in Vienna this week from September 16 - 21st, 2011.

“We are very pleased to join forces with such a strong strategic partner. Topcon's presence, commitment and reputation for quality is ideally positioned to market LensAR's superior laser system in the European market.”

Eric Franken, Managing Director, Topcon Europe Medical BV comments: "This is a very exciting opportunity for Topcon to significantly broaden our activities in ocular surgery. We are well known for our strengths in ocular diagnostics and now we intend to use our strong direct sales presence in Europe to market the LensAR™ Laser System to the benefit of our customers and their patients."

Randy Frey, President & CEO LensAR Inc comments: "We are very pleased to join forces with such a strong strategic partner. Topcon's presence, commitment and reputation for quality is ideally positioned to market LensAR's superior laser system in the European market."

Source:

 LensAR, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.